Facetten
Zugriff
Einrichtung
Medientyp
- Text 10
Karte
Erscheinungsjahr
Autor/in
- Langley, Richard G
- Blauvelt, Andrew 5
- Reich, Kristian 5
- Augustin, Matthias 3
- Paul, Carle 3
- alle zeigen
Sprache
10 Einträge gefunden
-
-
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study
- Blauvelt, Andrew
- Armstrong, April W
- Langley, Richard G
- Gebauer, Kurt
- Thaçi, Diamant
- Bagel, Jerry
- Guenther, Lyn C
-
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial
- Blauvelt, Andrew
- Langley, Richard G
- Lacour, Jean-Philippe
- Toth, Darryl
- Laquer, Vivian
- Beissert, Stefan
- Wollenberg, Andreas
-
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey
- Lebwohl, Mark
- Langley, Richard G
- Paul, Carle
- Puíg, Lluis
- Reich, Kristian
- van de Kerkhof, Peter
- Wu, Hsiuan-Lin
-
Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis
- Langley, Richard G
- Poulin, Yves
- Srivastava, Bhaskar
- Lafferty, Kimberly Parnell
- Fakharzadeh, Steven
- Langholff, Wayne
- Augustin, Matthias
-
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
- Reich, Kristian
- Papp, Kim A
- Blauvelt, Andrew
- Langley, Richard G
- Armstrong, April
- Warren, Richard B
- Gordon, Kenneth B
-
Bimekizumab versus Adalimumab in Plaque Psoriasis
- Warren, Richard B
- Blauvelt, Andrew
- Bagel, Jerry
- Papp, Kim A
- Yamauchi, Paul
- Armstrong, April
- Langley, Richard G
-
Bimekizumab versus Secukinumab in Plaque Psoriasis
- Reich, Kristian
- Warren, Richard B
- Lebwohl, Mark
- Gooderham, Melinda
- Strober, Bruce
- Langley, Richard G
- Paul, Carle
-
-
Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2.
- Reich, Kristian
- Schenkel, Brad
- Zhao, Ning
- Szapary, Philippe
- Augustin, Matthias
- Bourcier, Marc
- Guenther, Lyn